The 2021-2022 COI disclosure period runs until Sunday, October 31, 2021. If you are involved in any Research Submissions to IRB and/or OGC your COI must be submitted prior to this deadline.
CU is not directly affiliated with ACRP. Please email Laurie Burnside at laurie.burnside@outlook.com if you are interested in learning more about this class.
University Research is launching a new clinical research forum that will happen once a month via Zoom. Please take part to learn about the different resources available for you regarding your specific work.
The first session will begin in September 2021. There is no cost to attend the workshop, but space is limited. If interested in participating, please complete the registration application.
Any human subject research study conducted at CU Anschutz or external entity contracted under an OnCore clinical research affiliation agreement MUST be entered into and utilize the OnCore system.
Effective May 7th, the UCHealth Research Administration website transitioned to the Cloud. If you need access to this new site – you will need to contact 720-848-4000.
Federally funded clinical trials (e.g. by NIH or VAORD) are generally required to submit results to ClinicalTrials.gov within one year of the primary completion date. Failure to do so can lead to denial of future funding for both the investigator and the university. Their definition of "Clinical Trial" and the due date for results may be different than you think.
The Clinical Research Informatics and Innovation Unit (CRIIU) supports investigator-initiated research or innovation which requires integration and modification with Epic and other non-Epic clinical informatics innovations.
Reminder! If a project you’ve submitted to the HSR portal is not moving forward, please reach out to OnCore Support and the contract reviewer as soon as possible to let them know.
A new tip sheet is available on Research Administration’s The Source page which addresses frequently asked questions regarding investigational drugs at UCHealth.
In this on-demand webinar, FDA is providing background on investigational new drug (IND) safety reporting and will introduce listeners to the new guidance.
In this on-demand webinar, FDA is providing background on investigational new drug (IND) safety reporting and will introduce listeners to the new guidance.
As of June 1, 2021 The oversight of clinical research space is being delegated back to the clinical research space owner to manage in accordance with general campus COVID principles. Similar to the critical care environment, masks will still be required for researchers and participants during face-to-face research activities.
Beginning Tuesday, June 8, mask guidance for staff, providers, contractors and vendors who are fully vaccinated against COVID-19 will change. Please review the full announcement below.